About this document

Safety of Red Ginseng in Menopausal Women by andindl is a document available to read on EtoBox.

This study evaluates the safety of a red ginseng and herb extract complex (RHC) in menopausal women through a randomized, double-blind, placebo-controlled trial involving 120 participants. Results indicated that there were no significant differences in adverse reactions between the RHC and placebo groups, with only mild reactions reported and no severe adverse events. The findings confirm the safety of daily intake of 2 g of RHC for 12 weeks in menopausal women.

Author

andindl

Language

EN